Magpale, Michelle .

HRN: 25-79-84  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/13/2024
CEFUROXIME 500MG (TAB)
09/13/2024
09/19/2024
PO
1 Tab
Bid
Prom X 12hrs
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: